Attenuation of anti-tuberculosis therapy induced hepatotoxicity by Spirulina fusiformis, a candidate food supplement

References

• Adharyu MR, Reddy MN, Vakharia BC. (2008). Prevention of hepatotoxicity due to antituberculosis treatment: a novel integrative approach. World J Gastroenterol 14:4753–62
   PubMed Web of Science ®Google Scholar
• Amin A, Alaaeldin AH, Sayel D, Waleed H. (2006). Spirulina protects against cadmium-induced hepatotoxicity in rats. Am J Pharmacol Toxicol 1:21–5
   Google Scholar
• Attri S, Rana SV, Vaiphei K, et al. (2000). Isoniazid and rifampicin-induced oxidative hepatic injury protection by N-acetylcysteine. Hum Exp Toxicol 19:517–22
   PubMed Web of Science ®Google Scholar
• Bauer B, Yang X, Hartz AM, et al. (2006). In vivo activation of human pregnane X receptor tightens the blood brain barrier to methadone through P-glycoprotein up-regulation. Mol Pharmacol 70:1212–19
   PubMed Web of Science ®Google Scholar
• Beuhler RJ, Pierce RC, Friedman L, Siegelman HW. (1976). Cleavage of phycocyanobilin from C-phycocyanin. Separation and mass spectral identification of the products. J Biol Chem 251:2405–11
   PubMed Web of Science ®Google Scholar
• Bhosale VV, Tyagi A, Srivastava M, Gaur SPS. (2013). Incidence of hepatotoxicity in Indian patients receiving standard multidrug antitubercular therapy without risk factors. Clin Epidemiol 1:53–84
   Google Scholar
• Chowdhury A, Santra A, Bhattacharjee K, et al. (2006). Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice. J Hepatol 45:117–26
   PubMed Web of Science ®Google Scholar
• Christiane PM, Peter JM. (2006). Hepatobiliary transporters and drug induced cholestasis. Hepatology 44:778–87
   PubMed Web of Science ®Google Scholar
• Deng R, Chow TJ. (2010). Hypolipidemic, antioxidant, and antinflammatory activities of microalgae Spirulina. Cardiovasc Ther 28:e33–45
   PubMed Web of Science ®Google Scholar
• Dina SD, Yuval I, Ruth N, Haim JW. (2005). PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res 33:W363–7
   Web of Science ®Google Scholar
• Feng L, Jie L, Jie C, et al. (2013). Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy. Nat Med 19:418–20
   PubMed Web of Science ®Google Scholar
• Georgieva N, Gadjeva V, Tolekova A. (2004). New isonicotinoylhydrazones with SSA protect against oxidative-hepatic injury of isoniazid. TJS 2:37–43
   Google Scholar
• Goodwin B, Moore LB, Stoltz CM, et al. (2001). Regulation of the CYP2B6 gene by the nuclear pregnane X receptor. Mol Pharmacol 60:427–31
   PubMed Web of Science ®Google Scholar
• Heidari R, Babaei H, Eqhbal MA. (2013). Cytoprotective effects of taurine against toxicity induced by isoniazid and hydrazine in isolated rat hepatocytes. Arh Hiq Rada Toksikol 64:15–24
   PubMed Web of Science ®Google Scholar
• Jung D, Mangelsdorf DJ, Meyer UA. (2006). Pregnane X receptor is a target of Farnesoid X receptor. J Biol Chem 281:19081–91
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Goodwin B, Willson TM. (2002). The nuclear pregnane X receptor: a key regulator of Xenobiotic metabolism. Endocr Rev 23:687–702
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the folin phenol reagent. J Biol Chem 193:265–75
   PubMed Web of Science ®Google Scholar
• Marklund SL, Marklund G. (1974). Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–74
   PubMedGoogle Scholar
• Martin SJ, Mahima V, Lavinya BU, et al. (2014). Protective role of food supplement Spirulina fusiformis in chemical induced hepatotoxicity: a bromobenzene model in rats. Int J Pharmacol Res 4:4–9
   Google Scholar
• Minkova KM, Tchernov AA, Tchorbadjieva MI, et al. (2003). Purification of C-phycocyanin from Spirulina (Arthrospira)fusiformis. J Biotechnol 102:55–9
   PubMed Web of Science ®Google Scholar
• Mohamed FI, Doaa AA, Allal O. (2009). Chemoprevention of rat liver toxicity and carcinogenesis by Spirulina. Int J Biol Sci 5:377–87
   PubMed Web of Science ®Google Scholar
• Moron MS, Depierre JW, Mannervik B. (1979). Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67–78
   PubMed Web of Science ®Google Scholar
• Ohkawa H. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–8
   PubMed Web of Science ®Google Scholar
• Preziosi P. (2007). Isoniazid: metabolic aspects and toxicological correlates. Curr Drug Metab 8:839–51
   PubMed Web of Science ®Google Scholar
• Ravinder P, Vaiphei K, Arbab S, et al. (2006). Effect of garlic on isoniazid and rifampicin induced hepatic injury in rats. World J Gastroenterol 12:636–9
   PubMed Web of Science ®Google Scholar
• Ramaiah SK, Apte U, Mehendale HM. (2001). Cytochrome P4502E1 induction increases thioacetamide liver injury in diet restricted rats. Drug Metab Dispos 29:1088–95
   PubMed Web of Science ®Google Scholar
• Rasool M, Sabina EP. (2009). Appraisal of immunomodulatory potential of Spirulina fusiformis: an in vivo and in vitro study. J Nat Med 63:169–75
   PubMed Web of Science ®Google Scholar
• Rasool M, Sabina EP, Lavanya B. (2006). Anti-inflammatory effect of Spirulina fusiformis on adjuvant induced arthritis in mice. Biol Pharm Bull 29:2483–7
   PubMed Web of Science ®Google Scholar
• Rotruck JT, Pope AL, Ganther HE, et al. (1973). Selenium: biochemical role as a component of glutathione peroxidase purification and assay. Science 179:588–90
   PubMed Web of Science ®Google Scholar
• Sabina EP, Jaisy S, Segu R, et al. (2009). Hepatoprotective and antioxidant potential of Spirulina fusiformis on acetaminophen-induced hepatotoxicity in mice. Int J Integr Biol 6:1–5
   Google Scholar
• Sarich TC, Zhou T, Adams SP, et al. (1995). A model of isoniazid induced hepatotoxicity in rabbits. J Pharmacol Toxicol Methods 34:109–16
   PubMed Web of Science ®Google Scholar
• Sethumadhavan S, Theruvathil KS, Rangasamy A, Paruthapara TM. (2007). Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats. Eur J Pharmacol 572:69–73
   PubMed Web of Science ®Google Scholar
• Sharma SK, Mohan A. (2004). Extrapulmonary tuberculosis. Indian J Med Res 120:316–53
   PubMed Web of Science ®Google Scholar
• Sinha AK. (1972). Colorimetric assay of catalase. Anal Biochem 47:389–94
   PubMed Web of Science ®Google Scholar
• Sodhi CP, Rana SV, Mehta SK, et al. (1997). Study of oxidative-stress in isoniazid-rifampicin induced hepatic injury in young rats. Drug Chem Toxicol 20:255–69
   PubMed Web of Science ®Google Scholar
• Tasduq SA, Kaiser P, Sharma SC, Johri RK. (2007). Potentiation of isoniazid induced liver toxicity by rifampicin in a combinatorial therapy of antitubercular drugs (rifampicin, isoniazid and pyrazinamide) in Wistar rats: a toxicity profile study. Hepatol Res 37:845–53
   PubMed Web of Science ®Google Scholar
• Vidyasagar R, Guruprasad PA. (2013). Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management. J Clin Exp Hepatol 3:37–49
   PubMedGoogle Scholar
• Yue J, Peng R, Yang J, et al. (2004). CYP2E1 mediated isoniazid-induced hepatotoxicity in rats. Acta Pharmacol Sin 25:699–704
   PubMed Web of Science ®Google Scholar